Health Care & Life Sciences » Pharmaceuticals | Alfresa Holdings Corp.

Alfresa Holdings Corp.

Alfresa Holdings Corp.
Stock Exchange Tokyo Stock Exchange
EPS
JPY196.04
Market Cap
JPY583.8 B
Shares Outstanding
235.02 M
Public Float
174.84 M

Profile

Address
Ote Center Building, 23/F
Tokyo Tokyo 100
Japan
Employees -
Website http://www.alfresa.com
Updated 07/08/2019
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, Manufacturing, and Medical-related. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, medical devices, equipment, and materials to hospitals, clinics, dispensing pharmacies, and other institutions.

Financials

View All
Created with Highcharts 5.0.14Alfresa Holdings Corp.Net Income. Fiscal year is April-March. All values JPY Millions.25 56625 56622 92222 92234 97534 97530 89430 89435 59035 59041 69941 699201420152016201720182019010k20k30k40k50k
Created with Highcharts 5.0.14Alfresa Holdings Corp.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.2 504 5042 504 5042 421 1622 421 1622 576 4052 576 4052 551 9192 551 9192 602 9252 602 9252 640 5292 640 5292014201520162017201820190500k1 000k1 500k2 000k2 500k3 000k

Hiroyuki Kanome
Chairman
Taizo Kubo
President & Representative Director